Profiles of Drug Substances, Excipients, and Related Methodology, Volume 48 encompasses review articles and database compilations that fall within one or more of the following five broad categories: Physical Profiles of Drug Substances and Excipients; Analytical Profiles of Drug Substances and Excipients; ADME Profiles of Drug Substances and Excipients; Methodology Related to the Characterization of Drug Substances and Excipients; Methods of Chemical Synthesis. There is no comparable book series that gives this crucial information in such a timely and relevant manner. The volume offers in-depth profiles of Brimonidine, Cristine, Remdesivir, Vandetanib, and Lapatinib. It also includes an additional chapter on Pharmaceutical-Based Cosmetic Serums.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Preface - p. iii 8. Chapter One: Brimonidine - p. 1 9. Chapter Two: Crizotinib: A comprehensive profile - p. 42 10. Chapter Three: Remdesivir - p. 71 11. Chapter Four: Vandetanib - p. 113 12. Chapter Five: Lapatinib: A comprehensive profile - p. 138 13. Chapter Six: Pharmaceutical based cosmetic serums - p. 167 14. Cumulative index - p. 210
Profiles of Drug Substances, Excipients, and Related Methodology, Volume 48 encompasses review articles and database compilations that fall within one or more of the following five broad categories: Physical Profiles of Drug Substances and Excipients; Analytical Profiles of Drug Substances and Excipients; ADME Profiles of Drug Substances and Excipients; Methodology Related to the Characterization of Drug Substances and Excipients; Methods of Chemical Synthesis. There is no comparable book series that gives this crucial information in such a timely and relevant manner. The volume offers in-depth profiles of Brimonidine, Cristine, Remdesivir, Vandetanib, and Lapatinib. It also includes an additional chapter on Pharmaceutical-Based Cosmetic Serums.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Preface - p. iii 8. Chapter One: Brimonidine - p. 1 9. Chapter Two: Crizotinib: A comprehensive profile - p. 42 10. Chapter Three: Remdesivir - p. 71 11. Chapter Four: Vandetanib - p. 113 12. Chapter Five: Lapatinib: A comprehensive profile - p. 138 13. Chapter Six: Pharmaceutical based cosmetic serums - p. 167 14. Cumulative index - p. 210
